| 哒嗪酮类新衍生物的合成及其对血小板聚集的抑制作用 |
| 投稿时间：2011-05-10 修订日期：2011-08-26 点此下载全文 |
| 引用本文：王曙东,陈兴东,赵庆杰,邹燕,胡宏岗,俞世冲,汪亭,柴晓云,任海祥.哒嗪酮类新衍生物的合成及其对血小板聚集的抑制作用[J].药学实践杂志,2011,29(5):362~365 |
| 摘要点击次数: 1910 |
| 全文下载次数: 359 |
|
| 基金项目:上海市科委课题 (20054Y1700). |
|
| 中文摘要:目的 研究引入取代仲胺类基团对6-(4-取代乙酰氨基苯基)-5-甲基-4, 5-二氢-3(2H)-哒嗪酮类化合物抗血小板凝集活性的影响。 方法 设计合成未见报道的目标化合物 10 个,所有化合物均经过1H-NMR谱等确证;参考文献方法进行体外药理实验。 结果 所有化合物都具有抗血小板凝集的活性,其中化合物 9c,9f 和 9j 的抗血小板凝集活性明显优于对照药MCI-154和CCI-17910。 结论 取代仲胺基团的空间位阻和亲水性对化合物抗血小板凝集的活性有影响。 |
| 中文关键词:合成 哒嗪酮类 体外抗血小板聚集 体外活性 |
| |
| Synthesis and platelet aggregation inhibition activity of new derivatives of pyridazinone |
|
|
| Abstract:Objective To study the antiplatelet aggregative activity of 6-(4-substitued acetamino-phenyl 4, 5-dihydro-3(2H)-pyridazinones with different substituted secondary amines. Methods Ten target compounds were designed and synthesized.All of them were confirmed by 1H-NMR spectra. Born method was applied for preliminary pharmacological test in vitro. Results All of the target compounds were not reported.The results of preliminary pharmacological test showed that all the target compounds exhibited potent anti-platelet aggregative activity to a certain extent.Compounds 9c, 9f and 9j were better than MCI-154 and CCI-17910 in vitro. Conclution The steric hindrance and hydrophilicity of different substituted secondary amines impact the anti-platelete aggative activity. |
| keywords:synthesis pyridaziones platelet aggregation in vitro |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|
